Role of gastrointestinal microbial populations, a terra incognita of the human body in the management of intestinal bowel disease and metabolic disorders
In: Beneficial MicrobesSearch for other papers by J.E. Vazquez Bucheli in
Current site
Google Scholar
Search for other papers by S.D. Todorov in
Current site
Google Scholar
Search for other papers by W.H. Holzapfel in
Current site
Google Scholar
Intestinal bowel disease (IBD) is a chronic immune-mediated clinical condition that affects the gastrointestinal tract and is mediated by an inflammatory response. Although it has been extensively studied, the multifactorial aetiology of this disorder makes it difficult to fully understand all the involved mechanisms in its development and therefore its treatment. In recent years, the fundamental role played by the human microbiota in the pathogenesis of IBD has been emphasised. Microbial imbalances in the gut bacterial communities and a lower species diversity in patients suffering from inflammatory gastrointestinal disorders compared to healthy individuals have been reported as principal factors in the development of IBD. These served to support scientific arguments for the use of probiotic microorganisms in alternative approaches for the prevention and treatment of IBD. In a homeostatic environment, the presence of bacteria (including probiotics) on the intestinal epithelial surface activates a cascade of processes by which immune responses inhibited and thereby commensal organisms maintained. At the same time these processes may support activities against specific pathogenic bacteria. In dysbiosis, these underlying mechanisms will serve to provoke a proinflammatory response, that, in combination with the use of antibiotics and the genetic predisposition of the host, will culminate in the development of IBD. In this review, we summarised the main causes of IBD, the physiological mechanisms involved and the related bacterial groups most frequently associated with these processes. The intention was to enable a better understanding of the interaction between the intestinal microbiota and the host, and to suggest possibilities by which this knowledge can be useful for the development of new therapeutic treatments.
Purchase
Buy instant access (PDF download and unlimited online access):
Institutional Login
Log in with Open Athens, Shibboleth, or your institutional credentials
Personal login
Log in with your brill.com account
-
Abdelazez, A., Abdelmotaal, H., Evivie, S., Melak, S., Jia, F., Khoso, M.H., Zhu, Z., Zhang, L., Sami, R. and Meng, X., 2018. Screening potential probiotic characteristics of Lactobacillus brevis strains in vitro and intervention effect on Type I diabetes in vivo. Biomed Research International 2018: 7356173. https://doi.org/10.1155/2018/7356173
-
Al Nabhani, Z., Dietrich, G., Hugot, J. and Barreau, F., 2017. Nod2: the intestinal gate keeper. PLoS Pathogens 13: e1006177. https://doi.org/10.1371/journal.ppat.1006177
-
Alam, C., Bittoun, E., Bhagwat, D., Valkonen, S., Saari, A., Jaakkola, U., Eerola, E., Huovinen, P. and Hänninen, A., 2011. Effects of a germ-free environment on gut immune regulation and diabetes progression in non-obese diabetic (NOD) mice. Diabetologia 54: 1398-1406. https://doi.org/10.1007/s00125-011-2097-5
-
Alam, M., Amos, G., Murphy, A., Murch, S., Wellington, E. and Arasaradnam, R., 2020. Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels. Gut Pathogens 12: 1. https://doi.org/10.1186/s13099-019-0341-6
-
Alatab, S., Sepanlou, S., Ikuta, K., Vahedi, H., Bisignano, C., Safiri, S., Sadeghi, A., Nixon, M., Abdoli, A., Abolhassani, H., Alipour, V., Almadi, M., Almasi-Hashiani, A., Anushiravani, A., Arabloo, J., Atique, S., Awasthi, A., Badawi, A., Baig, A., Bhala, N., Bijani, A., Biondi, A., Borzì, A., Burke, K., Carvalho, F., Daryani, A., Dubey, M., Eftekhari, A., Fernandes, E., Fernandes, J., Fischer, F., Haj-Mirzaian, A., Aaj-Mirzaian, A., Hasanzadeh, A., Hashemian, M., Hay, S., Hoang, C., Househ, M., Ilesanmi, O., Jafari Balalami, N., James, S., Kengne, A., Malekzadeh, M., Merat, S., Meretoja, T., Mestrovic, T., Mirrakhimov, E., Mirzaei, H., Mohammad, K., Mokdad, A., Monasta, l., Negoi, I., Nguyen, T., Nguyen, C., Pourshams, A., Poustchi, H., Rabiee, M., Rabiee, N., Ramezanzadeh, K., Rawaf, D., Rawaf, S., Rezaei, N., Robinson, S., Ronfani, L., Saxena, S., Sepehrimanesh, M., Shaikh, M., Sharafi, Z., Sharif, M., Siabani, S., Sima, A., Singh, J., Soheili, A., Sotoudehmanesh, R., Suleria, H., Tesfay, B., Tran, B., Tsoi, D., Vacante, M., Wondmieneh, A., Zarghi, A., Zhang, Z., Dirac, M., Malekzadeh, R. and Naghavi, M., 2020. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017. The Lancet Gastroenterology and Hepatology 5: 17-30. https://doi.org/10.1016/s2468-1253(19)30333-4
-
Alhagamhmad, M., Day, A., Lemberg, D. and Leach, S., 2016. An overview of the bacterial contribution to Crohn disease pathogenesis. Journal of Medical Microbiology 65: 1049-1059. https://doi.org/10.1099/jmm.0.000331
-
An, M., Park, Y. and Lim, Y., 2021. Antiobesity and antidiabetic effects of the dairy bacterium Propionibacterium freudenreichii MJ2 in high-fat diet-induced obese mice by modulating lipid metabolism. Scientific Reports 11: 2481. https://doi.org/10.1038/s41598-021-82282-5
-
Anand, S., Kaur, H. and Mande, S., 2016. Comparative in silico analysis of butyrate production pathways in gut commensals and pathogens. Frontiers in Microbiology 7: 1945. https://doi.org/10.3389/fmicb.2016.01945
-
Arike, L. and Hansson, G., 2016. The densely O-glycosylated MUC2 mucin protects the intestine and provides food for the commensal bacteria. Journal of Molecular Biology 428: 3221-3229. https://doi.org/10.1016/j.jmb.2016.02.010
-
Bakshani, C., Morales-Garcia, A., Althaus, M., Wilcox, M., Pearson, J., Bythell, J. and Burgess, J., 2018. Evolutionary conservation of the antimicrobial function of mucus: a first defense against infection. NPJ Biofilms and Microbiomes 4: 14. https://doi.org/10.1038/s41522-018-0057-2
-
Baquero, F. and Nombela, C., 2012. The microbiome as a human organ. Clinical Microbiology and Infection 18: 2-4. https://doi.org/10.1111/j.1469-0691.2012.03916.x
-
Bian, X., Wu, W., Yang, L., Lv, L., Wang, Q., Li, Y., Ye, J., Fang, D., Wu, J., Jiang, X., Shi, D. and Li, L., 2019. Administration of Akkermansia muciniphila ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Frontiers in Microbiology 10: 2259. https://doi.org/10.3389/fmicb.2019.02259
-
Biasi, F., Leonarduzzi, G., Oteiza, P. and Poli, G., 2013. Inflammatory bowel disease: mechanisms, redox considerations, and therapeutic targets. Antioxidants and Redox Signaling 19: 1711-1747. https://doi.org/10.1089/ars.2012.4530
-
Bjarnason, I., Sission, G. and Hayee, B., 2019. A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn’s disease. Inflammopharmacology 27: 465-473. https://doi.org/10.1007/s10787-019-00595-4
-
Borgeraas, H., Johnson, L., Skattebu, J., Hertel, J. and Hjelmesaeth, J., 2017. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Obesity Reviews 19: 219-232. https://doi.org/10.1111/obr.12626
-
Bossenmeyer-Pourie, C., Kannan, R., Ribieras, S., Wendling, C., Stoll, I., Thim, L., Tomasetto, C. and Rio, M.C., 2002. The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. Journal of Cell Biology 157: 761-770. https://doi.org/10.1083/jcb200108056
-
Byndloss, M.X., Olsan, E.E., Rivera-Chávez, F., Tiffany, C.R., Cevallos, S.A., Lokken, K.L., Torres, T.P., Byndloss, A.J., Faber, F., Gao, Y., Litvak, Y., Lopez, C.A., Xu, G., Napoli, E., Giulivi, C., Tsolis, R.M., Revzin, A., Lebrilla, C.B. and Bäumler, A.J., 2017. Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion. Science 357: 570-575. https://doi.org/10.1126/science.aam9949
-
Brown, C., Davis-Richardson, A., Giongo, A., Gano, K., Crabb, D., Mukherjee, N., Casella, G., Drew, J.C., Ilonen, J., Knip, M., Hyöty, H., Veijola, R., Simell, T., Simell, O., Neu, J., Wasserfall, C.H., Schatz, D., Atkinson, M.A. and Triplett, E.W., 2011. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for Type 1 diabetes. PLoS ONE 6: e25792. https://doi.org/10.1371/journal.pone.0025792
-
Browne, P.D., Claassen, E. and Cabana, M.D. (eds.), 2017. Microbiota in health and disease: from pregnancy to early childhood. Wageningen Academic Publishers, Wageningen, the Netherlands.
'Microbiota in health and disease: from pregnancy to early childhood', ().
-
Bunesova, V., Lacroix, C. and Schwab, C., 2017. Mucin cross-feeding of infant Bifidobacteria and Eubacterium hallii. Microbial Ecology 75: 228-238. https://doi.org/10.1007/s00248-017-1037-4
-
Cani, P., Amar, J., Iglesias, M., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A., Fava, F., Tuohy, K., Chabo, C., Waget, A., Delmee, E., Cousin, B., Sulpice, T., Chamontin, B., Ferrieres, J., Tanti, J., Gibson, G., Casteilla, L., Delzenne, N., Alessi, M. and Burcelin, R., 2007. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772. https://doi.org/10.2337/db06-1491
-
Carvalho, F., Koren, O., Goodrich, J., Johansson, M., Nalbantoglu, I., Aitken, J., Su, Y., Chassaing, B., Walters, W., González, A., Clemente, J., Cullender, T., Barnich, N., Darfeuille-Michaud, A., Vijay-Kumar, M., Knight, R., Ley, R. and Gewirtz, A., 2012. Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice. Cell Host and Microbe 12: 139-152. https://doi.org/10.1016/j.chom.2012.07.004
-
Chai, L., Lu, Z., Zhang, X., Ma, J., Xu, P., Qian, W., Xiao, C., Wang, S., Shen, C., Shi, J. and Zheng-Hong, X., 2019. Zooming in on butyrate-producing clostridial consortia in the fermented grains of Baijiu via gene sequence-guided microbial isolation. Frontiers in Microbiology 10: 1397. https://doi.org/10.3389/fmicb.2019.01397
-
Chen, Y., Jin, Y., Stanton, C., Paul Ross, R., Zhao, J., Zhang, H., Yang, B. and Chen, W., 2020. Alleviation effects of Bifidobacterium breve on DSS-induced colitis depends on intestinal tract barrier maintenance and gut microbiota modulation. European Journal of Nutrition 60: 369-387. https://doi.org/10.1007/s00394-020-02252-x
-
Cho, N.H., Shaw, J., Karuranga, S., Huang, Y., Da Rocha Fernandes, J., Ohlrogge, A. and Malanda, B., 2018. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice 138: 271-281. https://doi.org/10.1016/j.diabres.2018.02.023
-
Clooney, A., Eckenberger, J., Laserna-Mendieta, E., Sexton, K., Bernstein, M., Vagianos, K., Sargent, M., Ryan, F., Moran, C., Sheehan, D., Sleator, R., Targownik, L., Bernstein, C., Shanahan, F. and Claesson, M., 2020. Ranking microbiome variance in inflammatory bowel disease: a large longitudinal 1intercontinental study. Gut 70: 499-510. https://doi.org/10.1136/gutjnl-2020-321106
-
Cook, G.A., Familari, M., Thim, L. and Giraud, A.S., 1999. The trefoil peptides TFF2 and TFF3 are expressed in rat lymphoid tissues and participate in the immune response. FEBS Letters 456: 155-159. https://doi.org/10.1016/S0014-5793(99)00940-0
-
Cone, R., 2009. Barrier properties of mucus. Advanced Drug Delivery Reviews 61: 75-85. https://doi.org/10.1016/j.addr.2008.09.008
-
Coretti, L., Natale, A., Cuomo, M., Florio, E., Keller, S., Lembo, F., Chiariotti, L. and Pero, R., 2017. The interplay between defensins and microbiota in Crohn’s disease. Mediators of Inflammation, Article ID: 8392523. https://doi.org/10.1155/2017/8392523
-
Cotta, M. and Forster, R., 2006. The family Lachnospiraceae, including the genera Butyrivibrio, Lachnospira and Roseburia. In: Dworkin, M., Falkow, S., Rosenberg, E., Schleifer, K.H. and Stackebrandt, E. (eds) The prokaryotes. Springer, New York, NY, USA, pp. 1002-1021. https://doi.org/10.1007/0-387-30744-3_35
-
Crost, E., Le Gall, G., Laverde-Gomez, J., Mukhopadhya, I., Flint, H. and Juge, N., 2018. Mechanistic insights into the cross-feeding of Ruminococcus gnavus and Ruminococcus bromii on host and dietary carbohydrates. Frontiers in Microbiology 9: 2558. https://doi.org/10.3389/fmicb.2018.02558
-
Darfeuille-Michaud, A., Boudeau, J., Bulois, P., Neut, C., Glasser, A., Barnich, N., Bringer, M., Swidsinski, A., Beaugerie, L. and Colombel, J. 2004. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology 127: 412-421. https://doi.org/10.1053/j.gastro.2004.04.061
-
De Preter, V., Arijs, I., Windey, K., Vanhove, W., Vermeire, S., Schuit, F., Rutgeerts, P. and Verbeke, K., 2012. Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis. Inflammatory Bowel Diseases 18: 2371-2380. https://doi.org/10.1002/ibd.22949
-
DeGrutola, A., Low, D., Mizoguchi, A. and Mizoguchi, E., 2016. Current understanding of dysbiosis in disease in human and animal models. Inflammatory Bowel Diseases 22: 1137-1150. https://doi.org/10.1097/MIB.0000000000000750
-
Del Chierico, F., Abbatini, F., Russo, A., Quagliariello, A., Reddel, S., Capoccia, D., Caccamo, R., GinanniCorradini, S., Nobili, V., De Peppo, F., Dallapiccola, B., Leonetti, F., Silecchia, G. and Putignani, L., 2018. Gut microbiota markers in obese adolescent and adult patients: age-dependent differential patterns. Frontiers in Microbiology 9: 1210. https://doi.org/10.3389/fmicb.2018.01210
-
Delday, M., Mulder, I., Logan, E. and Grant, G., 2018. Bacteroides thetaiotaomicron ameliorates colon inflammation in preclinical models of Crohn’s disease. Inflammatory Bowel Diseases 25: 85-96. https://doi.org/10.1093/ibd/izy281
-
Den Besten, G., Van Eunen, K., Groen, A., Venema, K., Reijngoud, D. and Bakker, B., 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research 54: 2325-2340. https://doi.org/10.1194/jlr.r036012
-
Depommier, C., Everard, A., Druart, C., Plovier, H., Van Hul, M., Vieira-Silva, S., Falony, G., Raes, J., Maiter, D., Delzenne, N., De Barsy, M., Loumaye, A., Hermans, M., Thissen, J., De Vos, W. and Cani, P., 2019. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nature Medicine 25: 1096-1103. https://doi.org/10.1038/s41591-019-0495-2
-
Derwa, Y., Gracie, D., Hamlin, P. and Ford, A., 2017. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics 46: 389-400. https://doi.org/10.1111/apt.14203
-
Din, A., Hassan, A., Zhu, Y., Zhang, K., Wang, Y., Li, T., Wang, Y. and Wang, G., 2020. Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism. Journal of Nutritional Biochemistry 79: 108353. https://doi.org/10.1016/j.jnutbio.2020.108353
-
Dogan, B., Scherl, E., Bosworth, B., Yantiss, R., Altier, C., McDonough, P., Jiang, Z., DuPont, H., Garneau, P., Harel, J., Rishniw, M. and Simpson, K., 2013. Multidrug resistance is common in Escherichia coli associated with ileal Crohn’s disease. Inflammatory Bowel Diseases 19: 141-150. https://doi.org/10.1002/ibd.22971
-
Drider, D., 2021. Gut microbiota is an important source of bacteriocins and their in situ expression can be explored for treatment of bacterial infections. Probiotics and Antimicrobial Proteins 13: 1759-1765. https://doi.org/10.1007/s12602-021-09843-y
-
Duncan, S., 2002. Roseburia intestinalis sp. nov., a novel saccharolytic, butyrate-producing bacterium from human faeces. International Journal of Systematic and Evolutionary Microbiology 52: 1615-1620. https://doi.org/10.1099/ijs.0.02143-0
-
Elliott, T.R., Hudspith, B.N., Wu, G., Cooley, M., Parkes, G., Quiñones, B., Randall, L., Mandrell, R.E., Fagerquist, C.K., Brostoff, J., Rayment, N.B., Boussioutas, A., Petrovska, L. and Sanderson, J.D., 2013. Quantification and characterization of mucosa associated and intracellular Escherichia coli in inflammatory bowel disease. Inflammatroy Bowel Diseases 19: 2326-2338. https://doi.org/10.1097/MIB.0b013e3182a38a92
-
Feng, Y., Wang, Y., Wang, P., Huang, Y. and Wang, F., 2018. Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy. Cellular Physiology and Biochemistry 49: 190-205. https://doi.org/10.1159/000492853
-
Fleischer, J., Bumbalo, R., Bautze, V., Strotmann, J. and Breer, H., 2015. Expression of odorant receptor Olfr78 in enteroendocrine cells of the colon. Cell and Tissue Research 361: 697-710. https://doi.org/10.1007/s00441-015-2165-0
-
Frank, D., St. Amand, A., Feldman, R., Boedeker, E., Harpaz, N. and Pace, N., 2007. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proceedings of the National Academy of Sciences of the USA 104: 13780-13785. https://doi.org/10.1073/pnas.0706625104
-
Fukui, H., 2016. Increased intestinal permeability and decreased barrier function: does it really influence the risk of inflammation? Inflammatory Intestinal Diseases 1: 135-145. https://doi.org/10.1159/000447252
-
Glas, J., Konrad, A., Schmechel, S., Dambacher, J., Seiderer, J., Schroff, F. Wetzke, M., Roeske, D., Török, H., Tonenchi, L., Pfennig, S., Haller, D., Griga, T., Klein, W., Epplen, J.T., Folwaczny, C., Lohse, P., Göke, B., Ochsenkühn, T., Mussack, T., Folwaczny, M., Müller-Myhsok, B. and Brand, S., 2008. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn’s disease in the German population. American Journal of Gastroenterology 103: 682-691. https://doi.org/10.1111/j.1572-0241.2007.01694.x
-
Gammoh, N., 2020. The multifaceted functions of ATG16L1 in autophagy and related processes. Journal of Cell Science 133: jcs249227. https://doi.org/10.1242/jcs.249227
-
Ghosh, S., He, H., Wang, J., Gehr, T. and Ghosh, S., 2018. Curcumin-mediated regulation of intestinal barrier function: the mechanism underlying its beneficial effects. Tissue Barriers 6: e1425085. https://doi.org/10.1080/21688370.2018.1425085
-
Gilijamse, P., Hartstra, A., Levin, E., Wortelboer, K., Serlie, M., Ackermans, M., Herrema, H., Nederveen, A., Imangaliyev, S., Aalvink, S., Sommer, M., Levels, H., Stroes, E.S.G., Groen, A., Kemper, M., De Vos, W., Nieuwdorp, M. and Prodan, A., 2020. Treatment with Anaerobutyricum soehngenii: a pilot study of safety and dose-response effects on glucose metabolism in human subjects with metabolic syndrome. NPJ Biofilms and Microbiomes 6: 16. https://doi.org/10.1038/s41522-020-0127-0
-
Goodrich, J., Waters, J., Poole, A., Sutter, J., Koren, O., Blekhman, R.R., Beaumont, M., Van Treuren, W., Knight, R., Bell, J., Spector, T., Clark, A. and Ley, R., 2014. Human genetics shape the gut microbiome. Cell 159: 789-799. https://doi.org/10.1016/j.cell.2014.09.053
-
Gophna, U., Sommerfeld, K., Gophna, S., Doolittle, W. and Veldhuyzen van Zanten, S., 2006. Differences between tissue-associated intestinal microfloras of patients with Crohn’s disease and ulcerative colitis. Journal of Clinical Microbiology 44: 4136-4141. https://doi.org/10.1128/jcm.01004-06
-
Guilbaud, A., Howsam, M., Niquet-Léridon, C., Delguste, F., Fremont, M., Lestavel, S., Maboudou, P., Garat, A., Schraen, S., Onraed, B., Foligné, B., Boulanger, É. and Tessier, F.J., 2020. The effect of Lactobacillus fermentum ME-3 treatment on glycation and diabetes complications. Molecular Nutrition and Food Research 64: 1901018. https://doi.org/10.1002/mnfr.201901018
-
Guirro, M., Costa, A., Gual-Grau, A., Herrero, P., Torrell, H., Canela, N. and Arola, L., 2019. Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: a multiomics approach. PLoS ONE 14: e0218143. https://doi.org/10.1371/journal.pone.0218143
-
Gurung, M., Li, Z., You, H., Rodrigues, R., Jump, D., Morgun, A. and Shulzhenko, N., 2020. Role of gut microbiota in type 2 diabetes pathophysiology. Ebiomedicine 51: 102590. https://doi.org/10.1016/j.ebiom.2019.11.051
-
Hall, L., Walshaw, J. and Watson, A., 2014. Gut microbiome in new-onset Crohn’s Disease. Gastroenterology 147: 932-934. https://doi.org/10.1053/j.gastro.2014.08.014
-
Hasan, A., Rahman, A. and Kobori, H., 2019. Interactions between host PPARs and gut microbiota in health and disease. International Journal of Molecular Sciences 20: 387. https://doi.org/10.3390/ijms20020387
-
Hasegwa, M., Yada, S., Liu, M., Kamada, N., Muñoz-Planillo, R., Do, N., Núñez, G. and Inohara, N., 2014. Interleukin-22 regulates the complement system to promote resistance against pathobionts after pathogen-induced intestinal damage. Immunity 41: 620-632. https://doi.org/10.1016/j.immuni.2014.09.010
-
Heap, G., So, K., Weedon, M., Edney, N., Bewshea, C., Singh, A., Annese, V., Beckly, J., Buurman, D. and Chaudhary, R., 2015. Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease. Journal of Crohn’s and Colitis 10: 149-158. https://doi.org/10.1093/ecco-jcc/jjv219
-
Heilbronner, S., Krismer, B., Brötz-Oesterhelt, H. and Peschel, A., 2021. The microbiome-shaping roles of bacteriocins. Nature Reviews Microbiology 19: 726-739. https://doi.org/10.1038/s41579-021-00569-w
-
Hepworth, M., Fung, T., Masur, S., Kelsen, J., McConnell, F., Dubrot, J., Withers, D., Hugues, S., Farrar, M.A., Reith, W., Eberl, G., Baldassano, R.N., Laufer, T., Elson, C. and Sonnenberg, G., 2015. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4 + T cells. Science 348: 1031-1035. https://doi.org/10.1126/science.aaa4812
-
Hillman, E., Lu, H., Yao, T. and Nakatsu, C., 2017. Microbial ecology along the gastrointestinal tract. Microbes and Environments 32: 300-313. https://doi.org/10.1264/jsme2.ME17017
-
Hong, Y., Nishimura, Y., Hishikawa, D., Tsuzuki, H., Miyahara, H., Gotoh, C., Choi, K., Feng, D., Chen, C., Lee, H., Katoh, K., Roh, S. and Sasaki, S., 2005. Acetate and propionate short chain fatty acids stimulate Adipogenesis via GPCR43. Endocrinology 146: 5092-5099. https://doi.org/10.1210/en.2005-0545
-
Hsieh, M., Tsai, W., Jheng, Y., Su, S., Wang, S., Lin, C., Chen, Y. and Chang, W., 2018. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Scientific Reports 8: 16791. https://doi.org/10.1038/s41598-018-35014-1
-
Hrdý, J., Alard, J., Couturier-Maillard, A., Boulard, O., Boutillier, D., Delacre, M., Lapadatescu, C., Cesaro, A., Blanc, P., Pot, B., Ryffel, B., Chamaillard, M. and Grangette, C., 2020. Lactobacillus reuteri 5454 and Bifidobacterium animalis ssp. lactis 5764 improve colitis while differentially impacting dendritic cells maturation and antimicrobial responses. Scientific Reports 10: 5345. https://doi.org/10.1038/s41598-020-62161-1
-
Hughes, E., Winter, M., Duerkop, B., Spiga, L., Furtado de Carvalho, T., Zhu, W., Gillis, C., Büttner, L., Smoot, M., Behrendt, C., Cherry, S., Santos, R., Hooper, L. and Winter, S., 2017. Microbial respiration and formate oxidation as metabolic signatures of inflammation-associated dysbiosis. Cell Host and Microbe 21: 208-219. https://doi.org/10.1016/j.chom.2017.01.005
-
Hugot, J., Laurent-Puig, P., Gower-Rousseau, C., Olson, J., Lee, J., Beaugerie, L. Naom, I., Dupas, J., Van Gossum, A., Orholm, M., Bonaiti-Pellie, C., Weissenbach, J., Mathew, C.G., Lennard-Jones, J.E., Cortot, A., Colombel, J. and Thomas, G., 1996. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature 379: 821-823. https://doi.org/10.1038/379821a0
-
James, W., 2008. WHO recognition of the global obesity epidemic. International Journal of Obesity 32 (Suppl. 7): S120-S126. https://doi.org/10.1038/ijo.2008.247
-
Jang, L., Choi, G., Kim, S., Kim, B., Lee, S. and Park, H., 2019. The combination of sport and sport-specific diet is associated with characteristics of gut microbiota: an observational study. Journal of the International Society of Sports Nutrition 16: 21. https://doi.org/10.1186/s12970-019-0290-y
-
Ji, Y., Park, S., Chung, Y., Kim, B., Park, H., Huang, E., Jeong, D., Jung, H., Kim, B., Hyun, C. and Holzapfel, W.H., 2019. Amelioration of obesity-related biomarkers by Lactobacillus sakei CJLS03 in a high-fat diet-induced obese murine model. Scientific Reports 9: 6821. https://doi.org/10.1038/s41598-019-43092-y
-
Jia, L., Li, D., Feng, N., Shamoon, M., Sun, Z., Ding, L., Zhang, H., Chen, W., Sun, J. and Chen, Y.Q., 2017. Anti-diabetic effects of Clostridium butyricum CGMCC0313.1 through promoting the growth of gut butyrate-producing bacteria in type 2 diabetic mice. Scientific Reports 7: 7046. https://doi.org/10.1038/s41598-017-07335-0
-
Jones, R., Mercante, J. and Neish, A., 2012. Reactive oxygen production induced by the gut microbiota: pharmacotherapeutic implications. Current Medicinal Chemistry 19(10): 1519-1529. https://doi.org/10.2174/092986712799828283
-
Kabwe, M., Vikram, S., Mulaudzi, K., Jansson, J. and Makhalanyane, T., 2020. The gut microbiota of rural and urban individuals is shaped by geography. BMC Microbiology 20: 257. https://doi.org/10.1186/s12866-020-01907-3
-
Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., Ikuyama, K., Kagoshima, M. and Tsuchida, T., 2013. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition 110: 1696-1703. https://doi.org/10.1017/s0007114513001037
-
Kang, S., Denman, S., Morrison, M., Yu, Z., Dore, J., Leclerc, M. and McSweeney, C., 2010. Dysbiosis of fecal microbiota in Crohn’s disease patients as revealed by a custom phylogenetic microarray. Inflammatory Bowel Diseases 16: 2034-2042. https://doi.org/10.1002/ibd.21319
-
Karimi, G., Jamaluddin, R., Mohtarrudin, N., Ahmad, Z., Khazaai, H. and Parvaneh, M., 2017. Single-species versus dual-species probiotic supplementation as an emerging therapeutic strategy for obesity. Nutrition, Metabolism and Cardiovascular Diseases 27: 910-918. https://doi.org/10.1016/j.numecd.2017.06.020
-
Kennedy, N., Lamb, C., Berry, S., Walker, A., Mansfield, J., Parkes, M., Simpkins, R., Tremelling, M., Nutland, S., Parkhill, J., Probert, C., Hold, G.L. and Lees, C.W., 2018. The impact of NOD2 variants on fecal microbiota in Crohn’s disease and controls without gastrointestinal disease. Inflammatory Bowel Diseases 24: 583-592. https://doi.org/10.1093/ibd/izx061
-
Kespohl, M., Vachharajani, N., Luu, M., Harb, H., Pautz, S., Wolff, S. Sillner, N., Walker, A., Schmitt-Kopplin, P., Boettger, T., Renz, H., Offermanns, S., Steinhoff, U. and Visekruna, A., 2017. The microbial metabolite butyrate induces expression of Th1-associated factors in CD4+ T cells. Frontiers in Immunology 8: 1036. https://doi.org/10.3389/fimmu.2017.01036
-
Kim, M., Kang, S., Park, J., Yanagisawa, M. and Kim, C., 2013. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145: 396-406. https://doi.org/10.1053/j.gastro.2013.04.056
-
Kim, D., Kim, S., Lee, J., Kim, J., Che, X., Ma, H., Seo, D.H., Kim, T.I., Kim, W.H., Kim, S.W. and Cheon, J.H., 2018a. Lactobacillus acidophilus suppresses intestinal inflammation by inhibiting endoplasmic reticulum stress. Journal of Gastroenterology and Hepatology 34: 178-185. https://doi.org/10.1111/jgh.14362
-
Kim, J., Yun, J., Kim, M., Kwon, O. and Cho, B., 2018b. Lactobacillus gasseri BNR17 supplementation reduces the visceral fat accumulation and waist circumference in obese adults: a randomized, double-blind, placebo-controlled trial. Journal of Medicinal Food 21: 454-461. https://doi.org/10.1089/jmf.2017.3937
-
Kocsis, T., Molnár, B., Németh, D., Hegyi, P., Szakács, Z., Bálint, Garami, A., Soós, A., Márta, K. and Solymár, M., 2020. Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials. Scientific Reports 10: 11787. https://doi.org/10.1038/s41598-020-68440-1
-
Kushkevych, I., Castro Sangrador, J., Dordevic, D., Rozehnalová, M., Černý, M., Fafula, R., Vítezová, M. and Rittmann, S., 2020. Evaluation of physiological parameters of intestinal sulfate-reducing bacteria isolated from patients suffering from IBD and healthy people. Journal of Clinical Medicine 9: 1920. https://doi.org/10.3390/jcm9061920
-
Larson, G., Falk, P. and Hoskins, L.C., 1988. Degradation of human intestinal glycosphingolipids by extracellular glycosidases from mucin-degrading bacteria of the human fecal flora. Journal of Biological Chemistry 263: 10790-10798.
'Degradation of human intestinal glycosphingolipids by extracellular glycosidases from mucin-degrading bacteria of the human fecal flora ' () 263 Journal of Biological Chemistry : 10790 -10798.
-
Lavasani, P., Motevaseli, E., Sanikhani, N. and Modarressi, M., 2019. Komagataeibacter xylinus as a novel probiotic candidate with high glucose conversion rate properties. Heliyon 5: e01571. https://doi.org/10.1016/j.heliyon.2019.e01571
-
Le, B. and Yang, S., 2018. Efficacy of Lactobacillus plantarum in prevention of inflammatory bowel disease. Toxicology Reports 5: 314-317. https://doi.org/10.1016/j.toxrep.2018.02.007
-
Lee, A., Gibson, D., Zhang, Y., Sham, H., Vallance, B. and Dutz, J., 2009. Gut barrier disruption by an enteric bacterial pathogen accelerates insulitis in NOD mice. Diabetologia 53: 741-748. https://doi.org/10.1007/s00125-009-1626-y
-
Lee, C., Kim, B., Kim, J., Chun, J., Im, J. and Kim, J., 2017. Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. International Immunopharmacology 51: 47-56. https://doi.org/10.1016/j.intimp.2017.07.023
-
Lee, J., Han, D., Jo, S., Lee, A., Park, C., Eun, C. and Lee, Y., 2019. Characteristics and pathogenic role of adherent-invasive Escherichia coli in inflammatory bowel disease: potential impact on clinical outcomes. PLoS ONE 14: e0216165. https://doi.org/10.1371/journal.pone.0216165
-
Lei-Leston, A., Murphy, A. and Maloy, K., 2017. Epithelial cell inflammasomes in intestinal immunity and inflammation. Frontiers in Immunology 8: 1168. https://doi.org/10.3389/fimmu.2017.01168
-
Leimkühler, S. and Iobbi-Nivol, C., 2015. Bacterial molybdoenzymes: old enzymes for new purposes. FEMS Microbiology Reviews 40: 1-18. https://doi.org/10.1093/femsre/fuv043
-
Lewis, J., Miedzybrodzka, E., Foreman, R., Woodward, O., Kay, R., Goldspink, D., Gribble, F. and Reimann, F., 2020. Selective stimulation of colonic L cells improves metabolic outcomes in mice. Diabetologia 63: 1396-1407. https://doi.org/10.1007/s00125-020-05149-w
-
Limketkai, B., Akobeng, A., Gordon, M. and Adepoju, A., 2020. Probiotics for induction of remission in Crohn’s disease. Cochrane Database of Systematic Reviews 7: CD006634. https://doi.org/10.1002/14651858.cd006634.pub3
-
Liu, Y., Yu, X., Zhao, J., Zhang, H., Zhai, Q. and Chen, W., 2020. The role of MUC2 mucin in intestinal homeostasis and the impact of dietary components on MUC2 expression. International Journal of Biological Macromolecules 164: 884-891. https://doi.org/10.1016/j.ijbiomac.2020.07.191
-
Loddo, I. and Romano, C., 2015. Inflammatory bowel disease: genetics, epigenetics, and pathogenesis. Frontiers in Immunology 6: 551. https://doi.org/10.3389/fimmu.2015.00551
-
Lu, Y., Fan, C., Li, P., Lu, Y., Chang, X. and Qi, K., 2016. Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Scientific Reports 6: 37589. https://doi.org/10.1038/srep37589
-
Macy, J., Ljungdahl, L. and Gottschalk, G., 1978. Pathway of succinate and propionate formation in Bacteroides fragilis. Journal of Bacteriology 134: 84-91. https://doi.org/10.1128/jb.134.1.84-91.1978
-
Macpherson, A. and Uhr, T., 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662-1665. https://doi.org/10.1126/science.1091334
-
Maldonado Galdeano, C., Cazorla, S., Lemme Dumit, J., Vélez, E. and Perdigón, G., 2019. Beneficial effects of probiotic consumption on the immune system. Annals of Nutrition and Metabolism 74: 115-124. https://doi.org/10.1159/000496426
-
Marietta, E., Gomez, A., Yeoman, C., Tilahun, A., Clark, C., Luckey, D.D.H., Murray, J.A., White, B.A., Kudva, Y.C. and Rajagopalan, G., 2013. Low incidence of spontaneous Type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS ONE 8: e78687. https://doi.org/10.1371/journal.pone.0078687
-
Mariño, E., Richards, J., McLeod, K., Stanley, D., Yap, Y., Knight, J. Mckenzie, C., Kranich, J., Oliveira, A.C., Rossello, F.J., Krishnamurthy, B., Nefzger, C.M., Macia, L., Thorburn, A., Baxter, A.G., Morahan, G., Wong, L.H., Polo, J.M., Moore, R.J., Lockett, T.J., Clarke, J.M., Topping, D.L., Harrison, L.C. and Mackay, C.R., 2017. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nature Immunology 18: 552-562. https://doi.org/10.1038/ni.3713
-
Matheus, V., Monteiro, L., Oliveira, R., Maschio, D. and Collares-Buzato, C., 2017. Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. Experimental Biology and Medicine 242: 1214-1226. https://doi.org/10.1177/1535370217708188
-
Mauricio, M., Serna, E., Fernández-Murga, M., Portero, J., Aldasoro, M., Valles, S.S.L., Sanz, Y. and Vila, J.M., 2017. Bifidobacterium pseudocatenulatum CECT 7765 supplementation restores altered vascular function in an experimental model of obese mice. International Journal of Medical Sciences 14: 444-451. https://doi.org/10.7150/ijms.18354
-
McFarland, L., 2020. Efficacy of single-strain probiotics versus multi-strain mixtures: systematic review of strain and disease specificity. Digestive Diseases and Sciences 66: 694-704. https://doi.org/10.1007/s10620-020-06244-z
-
McNabney, S. and Henagan, T., 2017. Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance. Nutrients 9: 1348. https://doi.org/10.3390/nu9121348
-
McNelis, J., Lee, Y., Mayoral, R., Van der Kant, R., Johnson, A., Wollam, J. and Olefsky, J., 2015. GPR43 potentiates β-cell function in obesity. Diabetes 64: 3203-3217. https://doi.org/10.2337/db14-1938
-
Metwaly, A., Dunkel, A., Waldschmitt, N., Raj, A.C.D., Lagkouvardos, I., Corraliza, A.M., Mayorgas, A., Martinez-Medina, M., Reiter, S., Schloter, M., Hofmann, T., Allez, M., Panes, J., Salas, A. and Haller, D., 2020. Integrated microbiota and metabolite profiles link Crohn’s disease to sulfur metabolism. Nature Communications 11: 4322. https://doi.org/10.1038/s41467-020-17956-1
-
Michael, D., Jack, A., Masetti, G., Davies, T., Loxley, K., Kerry-Smith, J.J., Plummer, J.F., Marchesi, J.R., Mullish, B.H., Mcdonald, J.A.K., Hughes, T.R., Wang, D., Garaiova, I., Paduchová, Z., Muchová, J., Good, M.A. and Plummer, S.F., 2020. A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being. Scientific Reports 10: 4183. https://doi.org/10.1038/s41598-020-60991-7
-
Mishra, S., Wang, S., Nagpal, R., Miller, B., Singh, R., Taraphder, S. and Yadav, H., 2019. Probiotics and prebiotics for the amelioration of Type 1 diabetes: present and future perspectives. Microorganisms 7: 67. https://doi.org/10.3390/microorganisms7030067
-
Mobini, R., Tremaroli, V., Ståhlman, M., Karlsson, F., Levin, M., Ljungberg, M., Sohlin, M., Bertéus Forslund, H., Perkins, R., Bäckhed, F. and Jansson, P., 2017. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial. Diabetes, Obesity and Metabolism 19: 579-589. https://doi.org/10.1111/dom.12861
-
Moens, F. and De Vuyst, L., 2017. Inulin-type fructan degradation capacity of Clostridium cluster IV and XIVa butyrate-producing colon bacteria and their associated metabolic outcomes. Benefitial Microbes 8: 473-490. https://doi.org/10.3920/BM2016.0142
-
Momozawa, Y., Dmitrieva, J., Théâtre, E., Deffontaine, V., Rahmouni, S., Charloteaux, B., Crins, F., Docampo, E., Elansary, M., Gori, A., Lecut, C., Mariman, R., Mni, M., Oury, C., Altukhov, I., Alexeev, D., Aulchenko, Y., Amininejad, L., Bouma, G., Hoentjen, F., Löwenberg, M., Oldenburg, B., Pierik, M.J., Vander Meulen-De Jong, A.E., Van der Woude, C., Visschedijk, M.C., Lathrop, M., Hugot, J., Weersma, R.K., De Vos, M., Franchimont, D., Vermeire, S., Kubo, M., Louis, E. and Georges, M., 2018. IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nature Communications 9: 2427. https://doi.org/10.1038/s41467-018-04365-8
-
Mukherjee, S., Zheng, H., Derebe, M.G., Callenberg, K.M., Partch, C.L., Rollins, D., Propheter, D.C., Rizo, J., Grabe, M., Jiang, Q.X. and Hooper, L.V., 2014. Antibacterial membrane attack by a pore-forming intestinal C-type lectin. Nature 505: 103-107. https://doi.org/10.1038/nature1272
-
Mukhopadhyay, S., Heinz, E., Porreca, I., Alasoo, K., Yeung, A., Yang, H. Schwerd, T., Forbester, J.L., Hale, C., Agu, C.A., Choi, Y.H., Rodrigues, J., Capitani, M., Jostins-Dean, L., Thomas, D.C., Travis, S., Gaffney, D., Skarnes, W.C., Thomson, N., Uhlig, H.H., Dougan, G. and Powrie, F., 2019. Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2. Journal of Experimental Medicine 217: e20180649. https://doi.org/10.1084/jem.20180649
-
Mukhtar, H., Yaqub, S. and Haq, I., 2020. Production of probiotic Mozzarella cheese by incorporating locally isolated Lactobacillus acidophilus. Annals of Microbiology 70: 56. https://doi.org/10.1186/s13213-020-01592-7
-
Munukka, E., Rintala, A., Toivonen, R., Nylund, M., Yang, B. Takanen, A. Hänninen, A., Vuopio, J., Huovinen, P., Jalkanen, S., and Pekkala, S. (2017). Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice. The ISME Journal 11: 1667-1679. https://doi.org/10.1038/ismej.2017.24
-
Müller, M., Hernández, M., Goossens, G., Reijnders, D., Holst, J., Jocken, J.W.E., Van Eijk, H., Canfora, E.E. and Blaak, E.E., 2019. Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans. Scientific Reports 9: 12151. https://doi.org/10.1038/s41598-019-48775-0
-
Murri, M., Leiva, I., Gomez-Zumaquero, J., Tinahones, F., Cardona, F., Soriguer, F. and Queipo-Ortuño, M., 2013. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Medicine 11: 46. https://doi.org/10.1186/1741-7015-11-46
-
Murugesan, S., Ulloa-Martínez, M., Martínez-Rojano, H., Galván-Rodríguez, F., Miranda-Brito, C., Romano, M., Piña-Escobedo, A., Pizano-Zárate, M., Hoyo-Vadillo, C. and García-Mena, J., 2016. Study of the diversity and short-chain fatty acids production by the bacterial community in overweight and obese Mexican children. European Journal of Clinical Microbiology and Infectious Diseases 34: 1337-1346. https://doi.org/10.1007/s10096-015-2355-4
-
Nada, R., Ebihara, S., Yen, H. and Tobe, T., 2020. Enterohaemorrhagic Escherichia coli activates nitrate respiration to benefit from the inflammatory response for initiation of microcolony-formation. BMC Microbiology 20: 261. https://doi.org/10.1186/s12866-020-01946-w
-
Neuman, H., Debelius, J., Knight, R. and Koren, O., 2015. Microbial endocrinology: the interplay between the microbiota and the endocrine system. FEMS Microbiology Reviews 39(4): 509-521. https://doi.org/10.1093/femsre/fuu010
-
Nguyen, N., Nguyen, X., Lane, J. and Wang, P., 2010. Relationship between obesity and diabetes in a US adult population: findings from the national health and nutrition examination survey, 1999-2006. Obesity Surgery 21: 351-355. https://doi.org/10.1007/s11695-010-0335-4
-
Niibo, M., Shirouchi, B., Umegatani, M., Morita, Y., Ogawa, A., Sakai, F. Kadooka, Y. and Sato, M., 2019. Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model. Journal of Dairy Science 102: 997-1006. https://doi.org/10.3168/jds.2018-15203
-
Nitzan, O., Elias, M., Peretz, A. and Saliba, W., 2016. Role of antibiotics for treatment of inflammatory bowel disease. World Journal of Gastroenterology 22: 1078. https://doi.org/10.3748/wjg.v22.i3.1078
-
Ogura, Y., Bonen, D., Inohara, N., Nicolae, D., Chen, F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R.H., Achkar, J., Brant, S.R., Bayless, T.M., Kirschner, B.S., Hanauer, S.B., Nuñez, G. and Cho, J.H., 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411: 603-606. https://doi.org/10.1038/35079114
-
Oh, G., Moon, W., Seo, K., Jung, K., Kim, J., Kim, S., Park, M.I. and Park, S.J., 2021. Therapeutic potential of Escherichia coli Nissle 1917 in clinically remission-attained ulcerative colitis patients: a hospital-based cohort study. Korean Journal of Gastroenterology 77: 12-21. https://doi.org/10.4166/kjg.2020.0119
-
Park, H., Lee, K., Yeo, S., Shin, H. and Holzapfel, W.H., 2017. Autoinducer-2 quorum sensing influences viability of Escherichia coli O157:H7 under osmotic and in vitro gastrointestinal stress conditions. Frontier in Microbiology 8: 1077. https://doi.org/10.3389/fmicb.2017.01077
-
Pascal, V., Pozuelo, M., Borruel, N., Casellas, F., Campos, D., Santiago, A., Martinez, X., Varela, E., Sarrabayrouse, G., Machiels, K., Vermeire, S., Sokol, H., Guarner, F. and Manichanh, C., 2017. A microbial signature for Crohn’s disease. Gut 66: 813-822. https://doi.org/10.1136/gutjnl-2016-313235
-
Patel, S.K., Velkoska, E. and Burrell, L.M., 2013. Emerging markers in cardiovascular disease: Where does angiotensin-converting enzyme 2 fit in? Clinical and Experimental Pharmacology and Physiology 40: 551-559. https://doi.org/https://doi.org/10.1111/1440-1681.12069
-
Patterson, A., Mulder, I., Travis, A., Lan, A., Cerf-Bensussan, N., Gaboriau-Routhiau, V., Garden, K., Logan, E., Delday, M.I., Coutts, A.G.P., Monnais, E., Ferraria, V.C., Inoue, R., Grant, G. and Aminov, R.I., 2017. Human gut symbiont Roseburia hominis promotes and regulates innate immunity. Frontiers in Immunology 8: 1166. https://doi.org/10.3389/fimmu.2017.01166
-
Peters, B., Shapiro, J., Church, T., Miller, G., Trinh-Shevrin, C., Yuen, E., Friedlander, C., Hayes, R. and Ahn, J., 2018. A taxonomic signature of obesity in a large study of American adults. Scientific Reports 8: 9749. https://doi.org/10.1038/s41598-018-28126-1
-
Petersson, J., Schreiber, O., Hansson, G., Gendler, S., Velcich, A., Lundberg, J., Roos, S., Holm, L. and Phillipson, M., 2011. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. American Journal of Physiology – Gastrointestinal and Liver Physiology 300: G327-G333. https://doi.org/10.1152/ajpgi.00422.2010
-
Petnicki-Ocwieja, T., Hrncir, T., Liu, Y., Biswas, A., Hudcovic, T., Tlaskalova-Hogenova, H. and Kobayashi, K., 2009. Nod2 is required for the regulation of commensal microbiota in the intestine. Proceedings of the National Academy of Sciences of the USA 106: 15813-15818. https://doi.org/10.1073/pnas.0907722106
-
Pound, L., Patrick, C., Eberhard, C., Mottawea, W., Wang, G., Abujamel, T., Vandenbeek, R., Stintzi, A. and Scott, F., 2015. Cathelicidin antimicrobial peptide: a novel regulator of islet function, islet regeneration, and selected gut bacteria. Diabetes 64: 4135-4147. https://doi.org/10.2337/db15-0788
-
Prantera, C. and Marconi, S., 2013. Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity. Therapeutic Advances in Gastroenterology 6: 137-156. https://doi.org/10.1177/1756283x12473675
-
Puddu, A., Sanguineti, R., Montecucco, F. and Viviani, G., 2014. Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes. Mediators of Inflammation 2014: 162021. https://doi.org/10.1155/2014/162021
-
Qu, L., Ren, J., Huang, L., Pang, B., Liu, X., Liu, X. Li, B. and Shan, Y., 2018. Antidiabetic effects of Lactobacillus casei fermented yogurt through reshaping gut microbiota structure in Type 2 diabetic rats. Journal of Agricultural and Food Chemistry 66: 12696-12705. https://doi.org/10.1021/acs.jafc.8b04874
-
Ridaura, V., Faith, J., Rey, F., Cheng, J., Duncan, A., Kau, A., Griffin, N., Lombard, V., Henrissat, B., Bain, J., Muehlbauer, M., Ilkayeva, O., Semenkovich, C., Funai, K., Hayashi, D., Lyle, B., Martini, M., Ursell, L., Clemente, J., Van Treuren, W., Walters, W., Knight, R., Newgard, C., Heath, A. and Gordon, J., 2013. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341: 1241214. https://doi.org/10.1126/science.1241214
-
Rodrigues, S., Van Aken, E., Van Bocxlaer, S., Attoub, S., Nguyen, Q.D., Bruyneel, E., Westley, B.R., May, F.E., Thim, L., Mareel, M., Gespach, C. and Emami, S., 2003. Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase-2 and EGF receptor signaling. FASEB Journal 17: 7-16. https://doi.org/10.1096/fj.02-0201com
-
Rojas-Feria, M., Romero-García, T., Fernández Caballero-Rico, J., Pastor Ramírez, H., Avilés-Recio, M., Castro-Fernandez, M., Chueca Porcuna, N., Romero-Gόmez, M., García, F., Grande, L. and Del Campo, J., 2018. Modulation of faecal metagenome in Crohn’s disease: Role of microRNAs as biomarkers. World Journal of Gastroenterology 24: 5223-5233. https://doi.org/10.3748/wjg.v24.i46.5223
-
Rohr, M.W., Narasimhulu, C.A., Rudeski-Rohr, T.A. and Parthasarathy, S., 2020. Negative effects of a high-fat diet on intestinal permeability: a review. Advances in Nutrition 11: 77-91. https://doi.org/10.1093/advances/nmz061
-
Rossi, O., Van Berkel, L., Chain, F., Tanweer Khan, M., Taverne, N., Sokol, H., Duncan, S.H., Flint, H.J., Harmsen, H.J.M., Langella, P., Samsom, J.N. and Wells, J.M., 2016. Faecalibacterium prausnitzii A2-165 has a high capacity to induce IL-10 in human and murine dendritic cells and modulates T cell responses. Scientific Reports 6: 18507. https://doi.org/10.1038/srep18507
-
Ryan, F., Ahern, A., Fitzgerald, R., Laserna-Mendieta, E., Power, E., Clooney, A., O’Donoghue, K., McMurdie, P., Iwai, S., Crits-Christoph, A., Sheehan, D., Moran, C., Flemer, B., Zomer, A., Fanning, A., O’Callaghan, J., Walton, J., Temko, A., Stack, W., Jackson, L., Joyce, S., Melgar, S., DeSantis, T., Bell, J., Shanahan, F. and Claesson, M., 2020. Colonic microbiota is associated with inflammation and host epigenomic alterations in inflammatory bowel disease. Nature Communications 11: 1512. https://doi.org/10.1038/s41467-020-15342-5
-
Saitoh, T., Fujita, N., Jang, M., Uematsu, S., Yang, B., Satoh, T., Omori, H., Noda, T., Yamamoto, N., Komatsu, M., Tanaka, K., Kawai, T., Tsujimura, T., Takeuchi, O., Yoshimori, T. and Akira, S., 2008. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production. Nature 456: 264-268. https://doi.org/10.1038/nature07383
-
Samuel, B., Shaito, A., Motoike, T., Rey, F., Backhed, F., Manchester, J., Hammer, R., Williams, S., Crowley, J., Yanagisawa, M. and Gordon, J., 2008. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proceedings of the National Academy of Sciences of the USA 105: 16767-16772. https://doi.org/10.1073/pnas.0808567105
-
Schellekens, H., Torres-Fuentes, C., van de Wouw, M., Long-Smith, C., Mitchell, A., Strain, C., Berding K., Bastiaanssen, T.F., Rea, K., Golubeva, A.V., Arboleya, S., Verpaalen, M., Pusceddu, M.M., Murphy, A., Fouhy, F., Murphy, K., Ross, P., Roy, B.L., Stanton, C., Dinan, T.G. and Cryan, J.F., 2021. Bifidobacterium longum counters the effects of obesity: Partial successful translation from rodent to human. Ebiomedicine 63: 103176. https://doi.org/10.1016/j.ebiom.2020.103176
-
Segain, J.P., Raingeard de la Blétière, D., Bourreille, A., Leray, V., Gervois, N., Rosales, C., Ferrier, L., Bonnet, C., Blottière, H.M. and Galmiche, J.P., 2000. Butyrate inhibits inflammatory responses through NF-kappa B inhibition: implications for Crohn’s disease. Gut 47: 397-403. https://doi.org/10.1136/gut.47.3.397
-
Sender, R., Fuchs, S. and Milo, R., 2016. Revised estimates for the number of human and bacteria cells in the body. PLoS Biology 14: e1002533. https://doi.org/10.1371/journal.pbio.1002533
-
Shen, J. and Xiao, Z., 2018. Antimicrobial peptides in gastrointestinal diseases. Cathelicidin in gastrointestinal disorders, 1st edition. Academic Press, Sichuan, Luzhou, China, pp. 61-76. https://doi.org/10.1016/C2017-0-01236-3
-
Shokryazdan, P., Faseleh Jahromi, M., Liang, J. and Ho, Y., 2017. Probiotics: from isolation to application. Journal of the American College of Nutrition 36: 666-676. https://doi.org/10.1080/07315724.2017.1337529
-
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P., Manicassamy, S., Munn, D., Lee, J., Offermanns, S. and Ganapathy, V., 2014. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40: 128-139. https://doi.org/10.1016/j.immuni.2013.12.007
-
Sokolov, E., 1997. Obesity and diabetes mellitus, 1st edition. CRC Press, Boca Raton, FL, USA.
'Obesity and diabetes mellitus, 1st edition', ().
-
Steed, H., Macfarlane, G., Blackett, K., Bahrami, B., Reynolds, N., Walsh, S., Cummings, J.H. and Macfarlane, S., 2010. Clinical trial: the microbiological and immunological effects of synbiotic consumption – a randomized double-blind placebo-controlled study in active Crohn’s disease. Alimentary Pharmacology and Therapeutics 32: 872-883. https://doi.org/10.1111/j.1365-2036.2010.04417.x
-
Sun, Z., Sun, X., Li, J., Li, Z., Hu, Q., Li, L., Hao, X., Song, M. and Li, C., 2019. Using probiotics for type 2 diabetes mellitus intervention: advances, questions, and potential. Critical Reviews in Food Science and Nutrition 60: 670-683. https://doi.org/10.1080/10408398.2018.1547268
-
Swidsinski, A., Sydora, B., Doerffel, Y., Loening-Baucke, V., Vaneechoutte, M., Lupicki, M., Scholze, J., Lochs, H. and Dieleman, L.A., 2007. Viscosity gradient within the mucus layer determines the mucosal barrier function and the spatial organization of the intestinal microbiota. Inflammatory Bowel Diseases 13: 963-970. https://doi.org/10.1002/ibd.20163
-
Szilagyi, A., 2019. Relationship(s) between obesity and inflammatory bowel diseases: possible intertwined pathogenic mechanisms. Clinical Journal of Gastroenterology 13: 139-152. https://doi.org/10.1007/s12328-019-01037-y
-
Tai, E., Wu, W., Wong, H. and Cho, C., 2007. A new role for cathelicidin in ulcerative colitis in mice. Experimental Biology and Medicine 232: 799-808. https://doi.org/10.3181/00379727-232-2320799
-
Tai, N., Wong, F. and Wen, L., 2015. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Reviews in Endocrine and Metabolic Disorders 16: 55-65. https://doi.org/10.1007/s11154-015-9309-0
-
Tailford, L., Crost, E., Kavanaugh, D. and Juge, N., 2015. Mucin glycan foraging in the human gut microbiome. Frontiers in Genetics 6: 81. https://doi.org/10.3389/fgene.2015.00081
-
Tezuka, H. and Ohteki, T., 2019. Regulation of IgA production by intestinal dendritic cells and related cells. Frontiers in Immunology 10: 1891. https://doi.org/10.3389/fimmu.2019.01891
-
Thingholm, L., Rühlemann, M., Koch, M., Fuqua, B., Laucke, G., Boehm, R., Bang, C., Franzosa, E., Hübenthal, M., Rahnavard, A., Frost, F., Lloyd-Price, J., Schirmer, M., Lusis, A., Vulpe, C., Lerch, M., Homuth, G., Kacprowski, T., Schmidt, C., Nöthlings, U., Karlsen, T., Lieb, W., Laudes, M., Franke, A. and Huttenhower, C., 2019. Obese individuals with and without Type 2 diabetes show different gut microbial functional capacity and composition. Cell Host and Microbe 26: 252-264. https://doi.org/10.1016/j.chom.2019.07.004
-
Tidjani Alou, M., Lagier, J. and Raoult, D., 2016. Diet influence on the gut microbiota and dysbiosis related to nutritional disorders. Human Microbiome Journal 1: 3-11. https://doi.org/10.1016/j.humic.2016.09.001
-
Turnbaugh, P., Bäckhed, F., Fulton, L. and Gordon, J., 2008. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host and Microbe 3: 213-223. https://doi.org/10.1016/j.chom.2008.02.015
-
Tyakht, A., Kostryukova, E., Popenko, A., Belenikin, M., Pavlenko, A., Larin, A., Karpova, I.Y., Selezneva, O.V., Semashko, T.A., Ospanova, E.A., Babenko, V.V., Maev, I.V., Cheremushkin, S.V., Kucheryavyy, Y.A., Shcherbakov, P.L., Grinevich, V.B., Efimov, O.I., Sas, E.I., Abdulkhakov, R.A., Abdulkhakov, S.R., Lyalyukova, E.A., Livzan, M.A., Vlassov, V.V., Sagdeev, R.Z., Tsukanov, V.V., Osipenko, M.F., Kozlova, I.V., Tkachev, A.V., Sergienko, V.I., Alexeev, D.G. and Govorun, V.M., 2013. Human gut microbiota community structures in urban and rural populations in Russia. Nature Communications 4: 2469.
'Human gut microbiota community structures in urban and rural populations in Russia ' () 4 Nature Communications : 2469.
-
Tyler, A., Kirsch, R., Milgrom, R., Stempak, J., Kabakchiev, B. and Silverberg, M., 2016. Microbiome heterogeneity characterizing intestinal tissue and inflammatory bowel disease phenotype. Inflammatory Bowel Diseases 22: 807-816. https://doi.org/10.1097/MIB.0000000000000674
-
Vamanu, E. and Rai, S., 2021. The link between obesity, microbiota dysbiosis, and neurodegenerative pathogenesis. Diseases 9: 45. https://doi.org/10.3390/diseases9030045
-
Van Herreweghen, F., De Paepe, K., Roume, H., Kerckhof, F. and Van de Wiele, T., 2018. Mucin degradation niche as a driver of microbiome composition and Akkermansia muciniphila abundance in a dynamic gut model is donor independent. FEMS Microbiology Ecology 94: fiy186. https://doi.org/10.1093/femsec/fiy186
-
Vatanen, T., Franzosa, E., Schwager, R., Tripathi, S., Arthur, T., Vehik, K., Lernmark, Å., Hagopian, W.A., Rewers, M.J., She, J., Toppari, J., Ziegler, A., Akolkar, B., Krischer, J.P., Stewart, C.J., Ajami, N.J., Petrosino, J.F., Gevers, D., Lähdesmäki, H., Vlamakis, H., Huttenhower, C. and Xavier, R.J., 2018. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562: 589-594. https://doi.org/10.1038/s41586-018-0620-2
-
Velasquez, M., Centron, P., Barrows, I., Dwivedi, R. and Raj, D., 2018. Gut microbiota and cardiovascular uremic toxicities. Toxins 10: 287. https://doi.org/10.3390/toxins10070287
-
Ventura, M. and Perozzi, G., 2011. Introduction to the special issue ‘Probiotic bacteria and human gut microbiota’. Genes and Nutrition 6: 203. https://doi.org/10.1007/s12263-011-0241-y
-
Veprik, A., Laufer, D., Weiss, S., Rubins, N. and Walker, M., 2016. GPR41 modulates insulin secretion and gene expression in pancreatic β-cells and modifies metabolic homeostasis in fed and fasting states. FASEB Journal 30: 3860-3869. https://doi.org/10.1096/fj.201500030r
-
Verma, A., Xu, K., Du, T., Zhu, P., Liang, Z., Liao, S., Zhang, J., Raizada, M.K., Grant, M.B. and Li, Q., 2020. Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice. Molecular Therapy – Methods and Clinical Development 17: 400. https://doi.org/10.1016/j.omtm.2020.02.002
-
Vester-Andersen, M., Mirsepasi-Lauridsen, H., Prosberg, M., Mortensen, C., Träger, C., Skovsen, K., Thorkilgaard, T., Nøjgaard, C., Vind, I., Krogfelt, K., Sørensen, N., Bendtsen, F. and Petersen, A., 2019. Increased abundance of proteobacteria in aggressive Crohn’s disease seven years after diagnosis. Scientific Reports 9: 13473. https://doi.org/10.1038/s41598-019-49833-3
-
Vojinovic, D., Radjabzadeh, D., Kurilshikov, A., Amin, N., Wijmenga, C., Franke, L., Ikram, M.A., Uitterlinden, A.G., Zhernakova, A., Fu, J., Kraaij, R. and Van Duijn, C.M., 2019. Relationship between gut microbiota and circulating metabolites in population-based cohorts. Nature Communications 10: 5813. https://doi.org/10.1038/s41467-019-13721-1
-
Wang, K., Liao, M., Zhou, N., Bao, L., Ma, K., Zheng, Z., Wang, Y., Liu, C., Wang, W., Wang, J., Liu, S. and Liu, H., 2019. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Reports 26: 222-235. https://doi.org/10.1016/j.celrep.2018.12.028
-
Wang, B., Hussain, A., Zhou, Y., Zeng, Z., Wang, Q., Zou, P., Gong, L., Zhao, P. and Li, W., 2020a. Saccharomyces boulardii attenuates inflammatory response induced by Clostridium perfringens via TLR4/TLR15-MyD8 pathway in HD11 avian macrophages. Poultry Science 99: 5356-5365. https://doi.org/10.1016/j.psj.2020.07.045
-
Wang, Y., You, Y., Tian, Y., Sun, H., Li, X., Wang, X., Wang, Y. and Liu, J., 2020b. Pediococcus pentosaceus PP04 ameliorates high-fat diet-induced hyperlipidemia by regulating lipid metabolism in C57BL/6N mice. Journal of Agricultural and Food Chemistry 68: 15154-15163. https://doi.org/10.1021/acs.jafc.0c05060
-
Waters, J. and Ley, R., 2019. The human gut bacteria Christensenellaceae are widespread, heritable, and associated with health. BMC Biology 17: 83. https://doi.org/10.1186/s12915-019-0699-4
-
Wei, S., Chen, Y. and Chen, M., 2015. Selecting probiotics with the abilities of enhancing GLP-1 to mitigate the progression of type 1 diabetes in vitro and in vivo. Journal of Functional Foods 18: 473-486. https://doi.org/10.1016/j.jff.2015.08.016
-
Wei, H., Wang, B. and Li, B., 2020. IL-10 and IL-22 in mucosal immunity: driving protection and pathology. Frontiers in Immunology 11: 1315. https://doi.org/10.3389/fimmu.2020.01315
-
Willemsen, L., 2003. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts. Gut 52: 1442-1447. https://doi.org/10.1136/gut.52.10.1442
-
Wrzosek, L., Miquel, S., Noordine, M., Bouet, S., Chevalier-Curt, M., Robert, V., Philippe, C., Bridonneau, C., Cherbuy, C., Robbe-Masselot, C., Langella, P. and Thomas, M., 2013. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biology 11: 61. https://doi.org/10.1186/1741-7007-11-61
-
Wu, G., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y., Keilbaugh, S., Bewtra, M., Knights, D., Walters, W., Knight, R., Sinha, R., Gilroy, E., Gupta, K., Baldassano, R., Nessel, L., Li, H., Bushman, F. and Lewis, J., 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105-108. https://doi.org/10.1126/science.1208344
-
Wu, Y., Quan, Y., Liu, Y., Liu, K., Li, H., Jiang, Z., Zhang, T., Lei, H., Radek, K.A., Li, D., Wang, Z., Lu, J., Wang, W., Ji, S., Xia, Z. and Lai, Y., 2016. Hyperglycaemia inhibits REG3A expression to exacerbate TLR3-mediated skin inflammation in diabetes. Nature Communications 7: 13393. https://doi.org/10.1038/ncomms13393
-
Xia, F., Cao, H., Du, J., Liu, X., Liu, Y. and Xiang, M., 2016. Reg3g overexpression promotes b cell regeneration and induces immune tolerance in nonobese-diabetic mouse model. Journal of Leukocyte Biology 99: 1131-1140. https://doi.org/10.1189/jlb.3A0815-371RRR
-
Xu, L.F., Teng, X., Guo, J. and Sun, M., 2012. Protective effect of intestinal trefoil factor on injury of intestinal epithelial tight junction induced by platelet activating factor. Inflammation 35: 308-315. https://doi.org/10.1007/s10753-011-9320-x
-
Yamamoto-Furusho, J., Villeda-Ramírez, M., Meza-Guillen, D. and Barreto-Zúñiga, R., 2020. ABCC7/CFTR expression is down-regulated in patients with active ulcerative colitis. Research Square 1: 1-12. https://doi.org/10.21203/rs.3.rs-22104/v1
-
Yang, J., Lee, Y., Kim, Y., Lee, S., Ryu, S., Fukuda, S., Hase, K., Yang, C., Lim, H. S., Kim, M., Kim, H., Ahn, S., Kwon, B., Ko, H. and Kweon, M., 2016. Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunology 10: 104-116. https://doi.org/10.1038/mi.2016.42
-
Yi, H., Hu, W., Chen, S., Lu, Z. and Wang, Y., 2017. Cathelicidin-WA improves intestinal epithelial barrier function and enhances host defense against Enterohemorrhagic Escherichia coli O157:H7 infection. Journal of Immunology 198: 1696-1705. https://doi.org/10.4049/jimmunol.1601221
-
Yu, P., Ke, C., Guo, J., Zhang, X. and Li, B., 2020. Lactobacillus plantarum L15 alleviates colitis by inhibiting LPS-mediated NF-κB activation and ameliorates DSS-induced gut microbiota dysbiosis. Frontiers in Immunology 11: 575173. https://doi.org/10.3389/fimmu.2020.575173
-
Zhang, Q., Wu, Y. and Fei, X., 2016. Effect of probiotics on glucose metabolism in patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Medicine 52: 28-34. https://doi.org/10.1016/j.medici.2015.11.008
-
Zeng, M., Inohara, N. and Nuñez, G., 2016. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunology 10: 18-26. https://doi.org/10.1038/mi.2016.75
-
Zhang, M., Zhou, L. and Yu, C., 2018. Faecalibacterium Prausnitzii produces butyrate to maintain TH17/TREG balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Gastroenterology 24: 1926-1940. https://doi.org/10.1016/s0016-5085(18)30586-9
-
Zhang, J., Wang, S., Zeng, Z., Qin, Y., Shen, Q. and Li, P., 2020. Anti-diabetic effects of Bifidobacterium animalis 01 through improving hepatic insulin sensitivity in type 2 diabetic rat model. Journal of Functional Foods 67: 103843. https://doi.org/10.1016/j.jff.2020.103843
-
Zhao, Y., Chen, F., Wu, W., Sun, M., Bilotta, A., Yao, S., Xiao, Y., Huang, X., Eaves-Pyles, T.D., Golovko, G., Fofanov, Y., D’souza, W., Zhao, Q., Liu, Z. and Cong, Y., 2018a. GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunology 11: 752-762. https://doi.org/10.1038/mi.2017.118
-
Zhao, J., Zhang, X., Liu, H., Brown, M. and Qiao, S., 2018b. Dietary protein and gut microbiota composition and function. Current Protein and Peptide Science 20(2): 145-154. https://doi.org/10.2174/1389203719666180514145437
-
Zhou, Q., Zhang, Y., Wang, X., Yang, R., Zhu, X., Zhang, Y., Chen, C., Yuan, H., Yang, Z. and Sun, L., 2020. Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American gut project. Nutrition and Metabolism 17: 90. https://doi.org/10.1186/s12986-020-00516-1
-
Zhu, W., Winter, M., Byndloss, M., Spiga, L., Duerkop, B., Hughes, E., Büttner, L., De Lima Romão, E., Behrendt, C., Lopez, C., Sifuentes-Dominguez, L., Huff-Hardy, K., Wilson, R., Gillis, C., Tükel, Ç., Koh, A., Burstein, E., Hooper, L., Bäumler, A. and Winter, S., 2018. Precision editing of the gut microbiota ameliorates colitis. Nature 553: 208-211. https://doi.org/10.1038/nature25172
-
Zocco, M., Dal Verme, L., Cremonini, F., Piscaglia, A., Nista, E., Candelli, M., Novi, M., Rigante, D., Cazzato, I.A., Ojetti, V., Armuzzi, A., Gasbarrini, G. and Gasbarrini, A., 2006. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Alimentary Pharmacology and Therapeutics 23: 1567-1574. https://doi.org/10.1111/j.1365-2036.2006.02927.x
Supplementary Materials
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 524 | 176 | 10 |
| Full Text Views | 20 | 3 | 0 |
| PDF Views & Downloads | 18 | 6 | 0 |
Role of gastrointestinal microbial populations, a terra incognita of the human body in the management of intestinal bowel disease and metabolic disorders
In: Beneficial MicrobesSearch for other papers by J.E. Vazquez Bucheli in
Current site
Google Scholar
PubMed
Search for other papers by S.D. Todorov in
Current site
Google Scholar
PubMed
Search for other papers by W.H. Holzapfel in
Current site
Google Scholar
PubMed
Intestinal bowel disease (IBD) is a chronic immune-mediated clinical condition that affects the gastrointestinal tract and is mediated by an inflammatory response. Although it has been extensively studied, the multifactorial aetiology of this disorder makes it difficult to fully understand all the involved mechanisms in its development and therefore its treatment. In recent years, the fundamental role played by the human microbiota in the pathogenesis of IBD has been emphasised. Microbial imbalances in the gut bacterial communities and a lower species diversity in patients suffering from inflammatory gastrointestinal disorders compared to healthy individuals have been reported as principal factors in the development of IBD. These served to support scientific arguments for the use of probiotic microorganisms in alternative approaches for the prevention and treatment of IBD. In a homeostatic environment, the presence of bacteria (including probiotics) on the intestinal epithelial surface activates a cascade of processes by which immune responses inhibited and thereby commensal organisms maintained. At the same time these processes may support activities against specific pathogenic bacteria. In dysbiosis, these underlying mechanisms will serve to provoke a proinflammatory response, that, in combination with the use of antibiotics and the genetic predisposition of the host, will culminate in the development of IBD. In this review, we summarised the main causes of IBD, the physiological mechanisms involved and the related bacterial groups most frequently associated with these processes. The intention was to enable a better understanding of the interaction between the intestinal microbiota and the host, and to suggest possibilities by which this knowledge can be useful for the development of new therapeutic treatments.
| All Time | Past 365 days | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 524 | 176 | 10 |
| Full Text Views | 20 | 3 | 0 |
| PDF Views & Downloads | 18 | 6 | 0 |
